Verb Srugical's first prototype demonstration to partners
Yesterday, Verb Surgical had its first technology demonstration--only to its development partners.
The company was distinguished in Fierce 15.
Source: Verb Surgical, Patrick Riley
"Verb Surgical Inc. announced today that the company has demonstrated 
its first digital surgery prototype to its collaboration partners at 
Ethicon Endo-Surgery, Inc., part of the Johnson & Johnson Medical 
Devices Companies, and Verily Life Sciences (formerly Google Life 
Sciences), as well as senior leadership from Johnson & Johnson and 
Alphabet Inc.
The digital surgery platform included all elements of the company’s 
five technology pillars – robotics, visualization, advanced 
instrumentation, data analytics, and connectivity – developed by Verb 
and its collaboration partners.
The latest demonstration was attended by executives from Ethicon, 
Verily, Johnson & Johnson and Alphabet, including Alex Gorsky, 
Chairman & CEO of Johnson and Johnson, and Sergey Brin, co-founder 
of Alphabet, Inc. and Google.
“This is a tremendous achievement for Verb and our collaboration 
partners at Ethicon, and Verily,” said Verb Surgical CEO Scott 
Huennekens. 
“Verb is a company driven by taking action for surgeons and 
patients.  Completing this prototype milestone was an achievement that 
we aimed for a year ago, and I’m excited to say we achieved it and are 
on track with our development schedule to deliver Surgery 4.0 with our 
platform,” continued Huennekens.  
"The team has made important progress since Verb was formed in August
 2015. The digitally-enabled surgery platform is a great example of how 
healthcare can be transformed through innovation," said Gary Pruden, 
Executive Vice President and Worldwide Chairman, Medical Devices, 
Johnson & Johnson.
Sergey Brin stated, "It is extremely exciting to see the hard work 
Verily has been doing in optics, electronics, software, and more to take
 the next big step toward saving lives. Thanks to all of our partners 
and collaborators at Johnson & Johnson, Verb, and others."
Scott Huennekens further noted that Verb has been demonstrating the 
working prototype to its stakeholders for the past several months.  
“Verb is in a very unique position to leverage technology in ways never 
imagined before,” said Huennekens, “and we’ve just taken one major step 
forward to creating the future of surgery.”"
The company was distinguished in Fierce 15.
Source: Verb Surgical, Patrick Riley



Comments